Regeneron Pharmaceuticals Inc Recall: EYLEA, (aflibercept) Injection, For Intravitreal inj
Regeneron Pharmaceuticals Inc Recall: EYLEA, (aflibercept) Injection, For Intravitreal inj is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Regeneron Pharmaceuticals Inc; Product: EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dos
| Recalling firm | Regeneron Pharmaceuticals Inc |
|---|---|
| Product | EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Glass Syringe, Rx only, Manufactured by: Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, NDC 61755-005-01, NDC (sample lot) 61755-005-54 |
| Reason for recall | Lack of Assurance of Sterility: Complaints of syringe breakage |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | USA nationwide. |
| Recall initiated | 20240515 |
| Recall number | D-0531-2024 |
| Category | drug |
| State | NY |
| Country | United States |
$29/mo
Try RecallGuard →